Review article: current treatment and future prospects for the management of acute coronary syndromes

1999 ◽  
Vol 45 (8) ◽  
Author(s):  
K Bhagat
Keyword(s):  
Acute Coronary Syndromes ◽  
Current Treatment ◽  
Review Article ◽  
Future Prospects ◽  
Coronary Syndromes

Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines?

2004 ◽  
Vol 147 (5) ◽  
pp. 859-864 ◽  
Author(s):  
Moti Haim ◽  
Alexander Battler ◽  
Solomon Behar ◽  
Paolo M Fioretti ◽  
Valentina Boyko ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndromes ◽  
Current Treatment ◽  
Coronary Syndromes

Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?

2005 ◽  
Vol 149 (1) ◽  
pp. 98-103 ◽  
Author(s):  
Zaza Iakobishvili ◽  
Solomon Behar ◽  
Valentina Boyko ◽  
Alexander Battler ◽  
David Hasdai
Keyword(s):  
Cardiogenic Shock ◽  
Acute Coronary Syndromes ◽  
Current Treatment ◽  
Coronary Syndromes

Inflammatory diseases: inflammation and cardiovascular disease

ESC CardioMed ◽  
2018 ◽  
pp. 1107-1109
Author(s):  
Luigi Marzio Biasucci ◽  
Giovanna Liuzzo
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Cardiovascular Disease ◽  
Lupus Erythematosus ◽  
Acute Coronary Syndromes ◽  
Inflammatory Diseases ◽  
Future Prospects ◽  
Systemic Lupus ◽  
Relapsing Remitting ◽  
Inflammatory Processes ◽  
Coronary Syndromes

An increasing body of evidence demonstrates that atherosclerosis shares similarities with other inflammatory/autoimmune diseases. Chronic autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis (RA), characterized by chronic relapsing–remitting systemic inflammation, are recognized as risk factors for accelerated atherosclerosis. Therapies directed towards inflammatory processes crucially reduce cardiovascular disease morbidity and mortality in patients with systemic lupus erythematosus and patients with RA. Furthermore, RA and other inflammatory diseases are associated with an increased incidence of acute coronary syndromes and poorer outcome. In this chapter, the major evidence in this field and the most important pathophysiological and therapeutic future prospects are critically discussed.

scholarly journals Cardiorenal Syndrome - A Review Article

2015 ◽  
Vol 16 (1) ◽  
pp. 39-45
Author(s):  
NS Neki
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Acute Coronary Syndromes ◽  
Kidney Injury ◽  
Cardiorenal Syndrome ◽  
Review Article ◽  
Different Types ◽  
Coronary Syndromes ◽  
Novel Biomarkers

Cardiorenal syndromes (CRS) describe the dynamic inter-relationship between heart and kidney malfunction. Recent studies have clearly defined its various types and pathophysiology. Improved survival, cardiovascular risk factors (diabetes, hypertension, dyslipidemia), diagnostic and therapeutic intervention are some contributors in its causation. Types 1 and 2 CRS involve acute and chronic cardiovascular disease (CVD) scenarios leading to acute kidney injury or accelerated chronic kidney disease. Types 3 and 4 CRS describe acute and chronic kidney disease leading primarily to heart failure, although it is possible that acute coronary syndromes, stroke, and arrhythmias could be CVD outcomes in these forms of CRS. Finally, CRS type 5 describes a simultaneous insult to both heart and kidneys, such as sepsis, where both organs are injured simultaneously. This article focuses on different types, pathophysiology, novel biomarkers, preventive and treatment aspects of cardiorenal syndromes.DOI: http://dx.doi.org/10.3329/jom.v16i1.22400 J MEDICINE 2015; 16 : 39-45

Sign in / Sign up

Export Citation Format

Share Document